AAN Annual Meeting
The Neurology Today Conference Reporter aims to keep neurologists up to date and fully informed about the most noteworthy news from major professional meetings.
Whether you are attending the meeting or reading about it remotely, you’ll be able to access daily, concise peer-reviewed reports from major neurology conferences via email blasts that are optimized for web and mobile viewing.
The Neurology Today Conference Reporter highlights only those papers and presentations deemed noteworthy by the Neurology Today editors. All reports are vetted and reviewed by our team of neurologist reviewers, as well. Each report includes commentary from independent experts and appears with additional perspectives in the print edition of Neurology Today.
Peer-reviewed by the Neurology Today Editors
From left to right: Editor-in-Chief Joseph E. Safdieh, MD, FAAN, assistant dean, clinical curriculum, Louis and Rachel Rudin Foundation Education Scholar, vice chairman for education, associate professor of neurology, Weill Cornell Medical College; Associate Editor Orly Avitzur, MD, MBA, FAAN, clinical assistant professor of neurology, New York Medical College; Associate Editor Deborah A. Hall, MD, PhD, FAAN, associate professor in the department of neurological sciences, Rush University Medical Center; and Associate Editor Barney J. Stern, MD, FAAN, vice chair for strategic planning in the department of neurology, Johns Hopkins University.
Hot Off the Press from the 2018 AAN Annual Meeting:
April 27—Microvascular Changes Identified in Chronic Traumatic Brain Injury
April 27—Retinal Nerve Fiber Layer Thickness May Hold Key to MS Progression
April 27—When to Restart Anticoagulation After Intracranial Hemorrhage in Patients with Mechanical Heart Valves
April 27—New Survey Reveals Gaps in Institutional Prion Safety Policy
April 26—Updated Analysis Supports Safety of Ocrelizumab in MS Patients
April 26—Neurotoxicity Associated with CAR T Cancer Therapy
April 26—Single-Dose Gene Replacement Therapy Improves Motor Function in SMA Type 1 Patients
April 25—Intravenous Eptinezumab Reduces Frequent Episodic Migraine
April 25—Antisense Oligonucleotide Lowers HTT Protein in Huntington's Disease Patients
April 25—Tau-Directed Monoclonal Antibody Is Safe for Progressive Supranuclear Palsy
April 25—Second Course of tPA Appears Safe in Recurrent Stroke
April 24—Relapse Rates in MOG-IgG Demyelination Drop After Rituximab
April 24—Novel Sequencing Identifies Infectious Agents in Mysterious Encephalitis Outbreak
April 24—Ultrasound Improves Lumbar Puncture Success in Overweight Patients
April 24—Women Who Were Seizure-Free Before Pregnancy Maintain Seizure Freedom